Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The conformational isomerism of
2-chlorocyclopentanone
and 2-bromocyclopentanone has been determined through the solvent dependence of the (1)H NMR (3)J(HH) coupling constants, theoretical calculations and infrared data, using the solvation theory for the treatment of NMR data. In
2-chlorocyclopentanone
, the energy difference (E(Psi-e)-E(Psi-a)), in the isolated molecule at B3LYP level of theory, between the pseudo-equatorial (Psi-e) and pseudo-axial (Psi-a) conformers is 0.42kcalmol(-1), which decreases in CCl(4) and in acetonitrile solutions, in good agreement with infrared data (nu(CO)), despite the uncertainties of the latter method. The conformational equilibrium for 2-bromocyclopentanone is also between the Psi-e and Psi-a conformations, with an energy difference (E(Psi-e)-E(Psi-a)), in the isolated molecule at B3LYP level of theory, is 0.85kcalmol(-1) which decreases in CCl(4) and in acetonitrile solutions, also in good agreement with infrared data.
Spectrochim Acta A
Mol
Biomol Spectrosc 2009 Jun
PMID:Conformational analysis of 2-halocyclopentanones by NMR and IR spectroscopies and theoretical calculations. 1920 Dec 55